Introduction
Acute bovine pulmonary edema and emphysema (ABPE) is caused by the formation, absorption and lung metabolism of 3-methylindole (3MI), a product of ruminal tryptophan (TRP) catabolism (Carlson and Dickinson, 1978) . The naturally occurring disease is associated with sudden transition to improved pasture (Selman et al., 1974; Hammond et al., 1979) and can be induced experimentally by oral TRP administration (Carlson et al., 1968) and by oral or iv 3MI infusion (Carlson et al., 1972 (Carlson et al., , 1975 . Biotransformation of 3MI by pulmonary cytochrome P450 enzymes is required for toxicity (Bray and Carlson, 1979) . Recent evidence indicates that lung injury may result from covalent binding of activated 3MI metabolites to cell macromolecules, and that glutathione may be involved in detoxication of these toxic intermediates .
One approach to the prevention of ABPE has been to determine ways to inhibit 3M1 formation by altering ruminal fermentation. Studies have demonstrated that monensin can effectively reduce 3MI production and prevent the clinical signs and pulmonary lesions of ABPE (Hammond et al., 1978 (Hammond et al., , 1980a Hammond and Carlson, 1980 J  I  I  I  *  I  *  I  9 I  ,  I  9 I  *  I  ,  I  9 I  "'  "  I  " |  '  I  "  I  I  I  "  I  "  I  '  I  "  I  "  I  '  I  "  I  "  I DAY 0 I 2 3 4 5 6 7 8 9 tO It 12 other polyether antibiotics has shown that lasalocid also can block the conversion of TRP to 3MI (Hammond and Carlson, 1980) . In a previous trial, however, lasalocid did not protect cows challenged with oral TRP from ABPE when administered at 200 mg'head-l'd-1 (Hammond et al., 1980a) . The purpose of the present study was to determine the dose at which lasalocid would effectively inhibit 3MI production and prevent ABPE induced by oral TRP administration.
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Materials and Methods
Twenty mature Hereford and Angus cows were fed a maintenance diet (NRC, 1976) for 3 wk. The diet consisted of 6.35 kg of a chopped bromegrass hay (IFN 1-00-890)-wheat straw (IFN 1-05-175) mixture containing 6 to 7% crude protein, and .5 kg of ground barley ~ head-i'd -1. The hay was group-fed at 1700 h and the barley supplement was individually fed in stanchions. Trace mineralized salt and water were provided ad libitum. On d 0 of the experimental period, five cows were randomly allotted to each of four treatment groups. Mean body weights for groups I through IV were 508, 506, 474 and 500 kg, respectively. Lasalocid 6 was mixed into the barley supplement and fed at 0, 200,400 and 600 tug'head -1-d -1 to cows in groups I through IV, respectively. Ruminal fluid samples (approximately .5 liter) were obGift of Hoffman-LaRoche, Inc., Nutley, NJ. 7 Ajinomoto Co., Inc., Tokyo, Japan. rained by esophageal tube on d 0, 2, 4, 6 and 12 of the experimental period (figure 1) to determine the effects of lasalocid on in viva volatile fatty acid (VFA) concentration and on in vitro conversion of TRP to 3MI and indole. Before feeding on d 6, cows were given an oral dose of .35 g TRP?/kg body weight in gelatin capsules to induce ABPE. Ruminal production of 3MI and indole was determined at 0, 12, 18, 24, 48, 72 and 96 h after TRP challenge (figure 1). Cows were monitored for clinical signs of ABPE throughout the experimental period and for 1 wk after the trial. Cows that died were necropsied to verify the lung damage.
Ruminal fluid for in vitro incubations was collected at 15 h postfeeding because maximum conversion of TRP to 3MI occurs at this time (Honeyfield et al., 1983) . Incubations in triplicate were performed according to the method of Hammond et al. (1978) . Fermentations were terminated with .5 ml saturated mercuric chloride at 10 h on d 4 and at 24 h on all other days. Ruminal fluid samples from cows receiving the highest level of lasalocid (600 mg'head-l'd -1) were incubated with an additional 5 /ag lasalocid/ml ruminal fluid to determine if this treatment would further reduce 3MI production. Samples were analyzed for 3MI, indole and VFA according to methods described previously . The method of protected least significant difference or pooled Student's t-tests were used for statistical analyses (Steel and Torrie, 1980) . Regression analysis was used to determine the relationship between lasalocid dose and 3MI, indole and VFA production (General Linear Models procedure; SAS, 1979). 9.2 + .7* 4.1 • .7 h 13.9 + 2.3 h 16.6 + 1.8g* 13.3 • .9* 600 + 5/~g/ml e 2.4-+ .1" 3.5 + .6 8.5 + .9 9.1 • 1.7" 5.6 + .7* avalues are means • SE 9 Statistical analysis was by pooled t-test 9 Incubations were for 10 h on d 4 and for24 h on all other days.
b'c'dMeans in columns that do not have at least one superscript in common differ (for comparisons between the 0 rag.head -1 .d -* group and other treatments, P<.01; for all other comparisons, P<.05). eReduction in 3MI or indole production was determined after addition of 5 #g/ml lasalocid to incubation mixtures of ruminal fluid from cows given oral doses of 600 mg lasalocid.head -1 .d-'.
f'g'hMeans in columns that do not have at least one superscript in common differ (P<.05).
1Due to morbidity and mortality of cows in this group, no ruminal samples were obtained for analysis. *P< 9 (600 vs 600 + 5 ~g/ml).
Results
Lasalocid treatment at all levels reduced the in vitro conversion of TRP to 3MI (P<.01; table 1). The lowest dose of lasalocid (200 mg" head-l.d -1) produced a striking decrease in 3MI production, which was further reduced (P<.05) when the lasalocid treatment level was increased to 600 rng'head -l"d -1. No enhanced inhibition of TRP conversion to 3MI occurred when ruminal fluid from cows given the 600-rag treatment was incubated with an additional 5 /~g lasalocid/ml (P>.05; table 1). Regression analysis of the relationship between lasalocid dose and in vitro conversion of TRP to 3MI revealed linear and quadratic effects, respectively, on d 2 (P<.00~01, P<.002; r2=.76), 4 (P<.0001, P< 9 r2=.86) and 6 (P<.0001, P<.0001; r2=.91). The effect of lasalocid treatment on the in vitro conversion of TRP to indole was variable (tabte 1). Additional lasalocid (5 /~g/ml) generally reduced (P<.05) indole production in samples from cows given 600 mg lasalocid/d. Linear and quadratic effects were observed when comparing lasalocid dose to indole production on d 2 (P<.0006, P<.01; r2= 9 4 (P<.001, P<.02; r2=.67) and 6 (P<.007, P>.05; r2=.49).
Ruminal 3MI production in response to oral TRP administration was inhibited in all cows treated with lasalocid (figure 2). Peak 3MI concentrations were observed 18 to 24 h post- [.-, (table 3) . Clinical signs were identical to those reported previously (Hammond et al., 1980a) . Three cows from group I died of ABPE at a mean survival time of 89 h postdosing (range: 44 to 150 h). One cow from group I died of complications stemming from an unsuspected, preexisting chronic esophageal injury. Thus, ruminal 3MI and indole production data from this animal were not used in subsequent analyses. No clinical signs of ABPE were observed in cows given lasalocid (groups II through IV) at any time during or after the experimental period (table 3) 
Discussion
Previous research has demonstrated the potential of the polyether antibiotics to inhibit 3MI production and reduce the incidence of ABPE (Hammond and Carlson, 1980; Hammond et al., 1980a) . The results of this study clearly demonstrate that lasalocid has similar properties. The lowest dose of lasalocid used (200 tug'head-i'd -1) produced a marked reduction in 3MI formation to approximately 14% of controls in vitro and 24% of controls in vivo, and eliminated the development of ABPE in cows challenged with TRP. These results confirm an earlier study in which lasalocid reduced the in vitro conversion of TRP to 3MI to 10 to 13% of controls (Hammond et al., 1978) . The close agreement between in vitro and intraruminal results demonstrates that in vitro testing can be successfully used to predict the in vivo response to lasalocid treatment. The incubation method employed in this study has been used to predict accurately the prophylactic effects of monensin on ruminal 3MI production . fDue to morbidity and mortality of cows in this group, no ruminal samples were obtained for analysis.
In a previous study, 100 mg lasalocid/head given twice daily did not reduce 3MI formation or prevent the onset of ABPE in TRP-dosed cows (Hammond et al., 1980a) . In contrast, the equivalent 200 mg/head dose given once daily in the present experiment afforded complete protection. It is unlikely that discrepancies in results between these two experiments can be explained by this difference in treatment protocol. An alternate reason may be that cows were exposed to lasal6cid for different lengths of time before the TRP challenge. In the present study, lasalocid was prefed for 6 d, while the drug was introduced 1 d before TRP administration in the earlier experiment. The longer pretreatment period may have permitted the ruminal lasalocid concentration to increase to a level that inhibited 3MI formation. Earlier in vitro research demonstrated that the relative effective inhibitory dose was higher for lasalocid than for monensin (Hammond and Carlson, 1980 ). An exposure period greater than 1 d may thus be required for lasalocid to be effective in preventing ABPE when administered at
It is unlikely that lasalocid must be fed at this level for as long as 6 d to ensure protection, however, because dramatic inhibition of 3MI production in vitro was observed after only 2 d. The results of this study demonstrate that an inverse relationship exists between lasalocid dose and 3MI production. Studies with monensin have shown this drug to be effective in preventing ABPE when given at 200 mg'head-l" d -l. However, the effects of monensin dosing at other levels are not known. Because a strong positive relationship exists between ruminal 3MI production and incidence of ABPE (Hammond et al., 1978 (Hammond et al., , 1979 (Hammond et al., , 1980a , it would be advantageous to determine whether higher levels of monensin would further suppress 3MI formation and thus correspondingly decrease the likelihood of ABPE. A limiting factor may be the palatability of larger amounts of monensin to cattle (Baile et al., 1979) . In contrast, cows in the present experiment readily consumed .5-kg supplements containing as much as 600 mg lasalocid'head -1 "d -1 .
In general, lasalocid treatment increased production of indole. Maximum ruminal indole concentrations were detected in cows given 400 mg lasalocid'head-l'd -1. Inhibition of 3MI formation apparently tended to shunt TRP catabolism towards indole production. Similar effects have been observed with monensin (Hammond et al., 1980a) . Indole in relatively high amounts is hemo!ytic in cattle but does not cause ABPE (Hammond et al., 1980b) . Clinical signs of indole toxicity such as hemoglobinuria were not detected in any cows during the study.
Ruminal VFA concentration was sensitive to lasalocid dose. The observed increase in propionate and decreases in acetate and butyrate levels were similar to results from in vitro (Bartley et al., 1979) and in vivo (Gutierrez et al., 1982) studies that tested the effects of graded levels of lasalocid on rumen microbial fermentation. In contrast to earlier research with monensin , lasalocid treatment increased total VFA concentration in cows given 600 mg/d. Lasalocid had the same effect on total VFA concentration in the study by Gutierrez et al. (1982) .
Lasalocid inhibited 3MI production and prevented ABPE in cows after TRP administration. Further studies are needed to test the potential of lasalocid to prevent ABPE under field conditions.
